載入...
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Russo |
| 出版: |
IMA-PRESS LLC
2009-12-01
|
| 叢編: | Современная ревматология |
| 主題: | |
| 在線閱讀: | https://mrj.ima-press.net/mrj/article/view/261 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|